Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

RBNZ's inflation target conundrum
Economy

Cameron Bagrie: RBNZ's inflation target conundrum

A debate is pending on the inflation target as economic pain rises.

Cameron Bagrie 25 Apr 2024
Digital currency's big privacy and security issues
Opinion

Peter Griffin: Digital currency's big privacy and security issues

Scheme may be a bridge too far unless it comes with watertight assurances.

Peter Griffin 25 Apr 2024
Fletcher steels its nerves
Opinion

Paul McBeth: Fletcher steels its nerves

The building giant’s steel restructuring shouldn’t have surprised anyone.

Paul McBeth 23 Apr 2024